Physician profile
Michael Randazzo
NPI 1568925147
$1,299.48
in general payments reported to CMS, 2019-2025
19 companies · $63.82 in 2025
The $63.82 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $342 · 2023: $673 · 2024: $221 · 2025: $63.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $957.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $957.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $220.81 | 2022-2025 | Brilinta, Farxiga, Wainua |
| Philips North America LLC | $162.95 | 2022-2024 | (P88) Igt Devices Fm |
| Edwards Lifesciences Corporation | $116.78 | 2023-2024 | Sapien 3 Ultra Resilia, Pascal |
| Novartis Pharmaceuticals Corporation | $102.80 | 2023 | |
| Janssen Pharmaceuticals, INC | $101.84 | 2022-2023 | Xarelto |
| Inari Medical, INC. | $90.83 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $78.68 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.61 | 2022-2023 | Lifevest |
| Lantheus Medical Imaging, INC. | $75.82 | 2022-2023 | Definity |
| Merck Sharp & Dohme LLC | $44.39 | 2022-2023 | Verquvo |
| Teleflex LLC | $33.73 | 2023 | Guideliner |
| Cardiva Medical, INC. | $30.41 | 2023 | Cardiva Vascade 6/7f Vcs |
| Boston Scientific Corporation | $29.75 | 2024 | Watchman Flx |
| Siemens Medical Solutions USA, INC. | $28.36 | 2025 | |
| Intuitive Surgical, INC. | $25.68 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $24.62 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.33 | 2023 | Livtencity |
| E.R. Squibb & Sons, L.L.C. | $15.56 | 2025 | Camzyos |
| Heartflow, INC. | $15.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Randazzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.